Turning Tragedy Into Discovery

Bipolar disorder research program named for auto pioneer Heinz C. Prechter

Author | Kara Gavin

Fifty years ago this spring, entrepreneur Heinz Prechter moved his company to Detroit to answer car buyers' fast-growing demand for sunroofs. But even as his products brought light into more than a million vehicles, he fought darkness in his own life. He struggled to keep his bipolar disorder hidden, until his suicide in July 2001 shocked the automotive industry. 

Heinz's wife, Waltraud "Wally" Prechter (A.B.Ed. 1979), created a fund in her husband's name in 2001 to help decipher bipolar illness. She moved the fund to the U-M Depression Center in 2004. She resolved to address the lack of scientific understanding about the condition and how best to treat it. 

"I think that if you can — if you truly believe in something — you owe it to yourself to help, to give and to make a difference. Because ultimately, that is all you leave behind." —Wally Prechter 

In May, U-M named its entire bipolar disorder research program for Heinz Prechter, in honor of a new gift commitment of up to $5 million by the World Heritage Foundation-Prechter Family Fund. 

The gift comes with a challenge to others who care about bipolar disorder: The Prechter family will match every dollar given to U-M bipolar disease research up to $5 million. This will double the value of every donation, and the Prechter family gift will be available to researchers faster, if others step in to support the cause. 

Once the challenge is met, the Prechter family's total giving to U-M bipolar research since Heinz Prechter's death will be well over $10 million. Philanthropic gifts, including individual, foundation and corporate gifts, are critical to the effort and account for more than half of the research funding in any given year. The Prechter family set up this gift as a match to encourage more philanthropic support of research into bipolar disorder. 

Heinz C. Prechter

"I think that if you can — if you truly believe in something — you owe it to yourself to help, to give and to make a difference. Because ultimately, that is all you leave behind," says Wally Prechter. 

Says U-M president Mark Schlissel, M.D., Ph.D., "I deeply appreciate Wally Prechter's commitment to advancing bipolar disease research that will give hope to millions of people around the world. The Heinz C. Prechter Bipolar Research Program will enhance the University of Michigan's longstanding research initiatives and drive new medical discoveries to combat this devastating disorder." 

"When we lost Heinz to his disease, it took Wally's bravery and generosity to help us create incredible good out of such a tragic loss," says John Greden, M.D., who was working with Heinz and Wally Prechter to create the U-M Depression Center at the time of Heinz's death. Greden is the Depression Center's director and the Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences. 

"Without Wally Prechter's leadership over the past decade, we would not have been able to develop the world's first bipolar-specific stem cell lines, discover new genetic links, explore environmental factors or bring experts worldwide together as we have," says Melvin McInnis, M.D., the Thomas B. and Nancy Upjohn Woodworth Professor of Bipolar Disorder, professor of psychiatry and director of the newly named Heinz C. Prechter Bipolar Research Program. 

The Prechter family is committed to increasing scientific understanding and treatment options that will enable people with bipolar disorder to lead healthy and productive lives. The new gift will grow the endowment that provides for the continuation of the Prechter Longitudinal Study of Bipolar Disorder, which has been ongoing for 11 years. 

The Longitudinal Study allows researchers to track symptoms, response to treatment and overall health over time in new ways. Already, more than 1,200 dedicated individuals have partnered with the research team to track personal and medical information for this long-term study. "Our participants are the real heroes," says Wally Prechter. "The goal of the Prechter Program is to identify effective solutions for people with bipolar disorder." 

Volunteers also can donate samples of their blood, giving scientists the chance to study tiny differences in DNA that may play a role in how the disorder develops, why it runs in families, how it affects people over time and what makes people vary in their response to treatment. The bank of DNA from hundreds of research participants over the last decade is called the Heinz C. Prechter Bipolar Genetics Repository, and it is the nation's largest privately funded bipolar genetics repository. 

"We look forward to fueling new discoveries, and involving hundreds more people with bipolar and their families in the search for better treatments. The new funding, from the Prechters and others who believe in our work, will allow us to accelerate our pace of discovery," says McInnis. 

The Heinz C. Prechter Bipolar Research Program will be the umbrella program over the Longitudinal Study of Bipolar Disorder and other bipolar research studies. For more information, visit prechterprogram.org


More Articles About: Development impact bipolar disorder Prechter depression center Research
Featured News & Stories Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Access to Plan B coincides with a drastic decrease in emergency contraception-related ER visits, study shows
U.S. emergency departments see 96% fewer visits, $7.6 million less in medical costs after FDA approval of over the counter emergency contraception.
News Release
Statewide cardiovascular consortium, hosted at Michigan Medicine, receives national award for patient safety, quality efforts
A collaborative partnership dedicated to improving statewide cardiovascular care and outcomes — hosted at Michigan Medicine — received national recognition for efforts in patient safety and quality. BMC2 received the award for its significant improvements in the documentation of radiation use, a decrease in high-dose radiation exposure and reduction in opioid prescribing rates for patients.
Dark staircase leading to blue sky above
Health Lab
Ketamine’s promise for severe depression grows, but major questions remain
New findings about the impact of IV ketamine on treatment resistant depression add more fuel to the potential for broader use and insurance coverage.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Identifying Dementia from EHR Data
In 2009, the Health Information Technology for Economic and Clinical Health Act, wow, that's a mouthful, more commonly known as the HITECH Act, spent billions to promote the uptake of electronic health records by US hospitals. Fast forward more than a decade later, and now approximately four out of five healthcare institutions have electronic health record systems in place that integrate clinical notes, test results, medications, diagnostic images, et cetera. The adoption of EHR systems into healthcare introduces new and exciting opportunities to extract information that can be used to augment other types of data for research. As you might imagine though, it can be tricky to pull out meaningful information from the text of clinical notes. In this episode, we'll speak with a University of Michigan researcher, Dr. Vinod Vydiswaran, who's been developing methods to identify dementia from EHR data.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Study finds bipolar disorder surpasses smoking in mortality risk
A large study shows having bipolar disorder is associated with a four- to six-fold risk of dying prematurely, suggesting more preventive efforts needed. Visit Health Lab to read the full story.
Colorful painting of two heads
Health Lab
Bipolar disorder linked to early death more than smoking
People with bipolar disorder have a higher risk of early death than people who smoke, and more efforts to improve detection and care are needed.